Tag | Content |
---|
EnhancerAtlas ID | HS109-13046 | Organism | Homo sapiens | Tissue/cell | Kasumi-1 | Coordinate | chr2:172876360-172877610 | TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Gfi1b | MA0483.1 | chr2:172877481-172877492 | AAATCACAGCT | + | 6.14 |
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
| | Number: 1 | ID | Chromosome | Start | End |
GH02I172011 | chr2 | 172876508 | 172877507 |
| Enhancer Sequence | TTTTGTATTT TTAGTAGAGA CGGGGTTTCA CTGTGTTAGC CAGGCTGGTC TCGATCTCCT 60 GACCTCGTGA TCCTCCTGCC TTGGCCTCCC AAAGTGCTGG GATTACAGGC GTGAGCCACC 120 GCGCCCGGCC TAATCTTTCT GTTTCTATAG ATTTGCCTCT CCTGGACATT TCATATAATG 180 GAATCATACA ACATGCAGTC TTTTGTGACT GGCTTCTTTC ATTTAGCATG ATGTTTTCAT 240 GGTTCATCCC TATTGTGGCA TGTGTCAGTT TATTGCTGTA TAATATGCCA CTGTATGGAT 300 ATATCACATT TTGTTTATCC ATTCACCAGT TTGTGGACAT TTGGGTCATT TCTACTTTTT 360 AGTTCTTATG AATAATGCTA CTATGAATAT TTGTGTATGT GTTTTTCTGC GGACATATAT 420 TTTGTTTTGG TTTTGAAATA GGCTATGTTT AGATGCAGAG GGAAGCAAAG AAACTGGTAA 480 GGATGTGGTA AAATTACCAC ATCCACAAGA CAACGTTTAT TAAGTACTGA AATATTCCTT 540 TATGAAAGTT AACTCTTGCC ATCCCTTTTA TCTTTCACAT TTAGAGTCTA TATTATCACA 600 ACCTTGTTTT TCCTTTGAGT CAGCATTGTG ATCATTCTGG ACGTGGGGTC CCACACACCC 660 TGTCTCTGTC AGTAAGATTA TGATTAAGAT CAAATAGAAA TAGGTCAGGA GAGAAAAGAG 720 CTCCCTGGCC TTATTCTCCT CAAACTAGCT GATGCTCCTG AATACCAACC TCTTTAAGAA 780 TTGATATTTC AAAGGACAAC TCCTCTCTGT GGTCTTCTGT CCTCTCTCCC CTACTTTATG 840 CTCTGTGCAT AGCAGCTGTT CAGGACATCG CCCGAGCGCA GGGGCACTGC AATCAGAAAA 900 GCGAGTGAGG GACACAGCAG GAGAAGGCTG TTCTGGGGCT AGTGAGTGGG AGACGGGACA 960 AACAGCTAGA TAGCAACGTG ATGGCTTCAC CATGGGGTGA AGCGTGGGGG AGAGTATCAA 1020 TTACCTAGAT TTTAAAAAGA GAGCCCTTGA ACACCTCTGT CACTGGTCAC TTTTACCAAA 1080 GCCTTCTAAC TTAACGGAAG GAGATGCTGC ACTTTAAAGA AAAATCACAG CTGCGGAAGA 1140 CAGTCTTGCA AAGCCAGTTT TTGTGGCTTA GTATTTTGGG GTAGCTTGTT TCATGAGGGT 1200 CAGATTAATT TTCTAATGTT GTTTTCTACC TTAATGTTAC TGCTTTAATC 1250
|
| |
|
|
|